-
JP Morgan Comments on Trial Completion of Baxter's Alzheimer's Drug
Thursday, July 14, 2011 - 7:35am | 112“We confirmed on Wednesday that the first of Baxter's (NYSE: BAX) two phase III IVIG for Alzheimer's trials has now completed enrollment,” JP Morgan wrote in a report this morning. “An additional 30 patients were enrolled in the trial versus plan bringing total enrollment to 390 patients...
-
Benchmark Reiterates Hold on Meredith Corporation
Thursday, July 14, 2011 - 6:55am | 52Benchmark reiterated its Hold rating on Meredith Corporation (NYSE: MDT). At the moment, Benchmark has a price target of $35 placed on the company's stock. On Wednesday, MDT closed the day at $37.56. Its shares added 0.7% to their value in today's pre-market trading to stand around $37.82.
-
Stocks to Watch for Thursday 7/14/2011: Fresh 52 Week Highs and Lows
Thursday, July 14, 2011 - 2:29am | 1820Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels. The following stocks hit new 52-week highs in Wednesday's trading session (listed from highest total volume to lowest): 1) SPDR Gold Shares (NYSE: GLD):...
-
Earnings Scheduled For July 14
Thursday, July 14, 2011 - 2:22am | 232AngioDynamics Inc (NASDAQ: ANGO) is expected to report its Q4 EPS at $0.10 on revenue of $56.96 million. Fairchild Semiconductor International Inc (NYSE: FCS) is estimated to report its Q2 earnings at $0.40 per share on revenue of $430.27 million. Nexen Inc (NYSE: NXY) is projected to report its...
-
Boston Scientific Earnings Preview: Revenue, Earnings Expected to Fall from Previous Quarter
Wednesday, July 13, 2011 - 12:44pm | 425Get ready for Boston Scientific (NYSE: BSX) earnings! Don't be the last to know: The company announces its next round of earnings this Monday, July 18, 2011. No time to prep before Monday's announcement? Don't worry. Here is your everything-that-matters guide to Boston Scientific's second quarter...
-
Edwards Lifesciences' Advanced Critical Care Platform Now Available in the U.S.
Wednesday, July 13, 2011 - 11:01am | 137Edwards Lifesciences Corporation (NYSE: EW) today announced that the U.S. Food and Drug Administration (FDA) has given 510k clearance for its new EV1000 clinical monitoring platform. With a touch-screen monitor that displays a patient's physiologic status and user-friendly clinical targets and...
-
UPDATE: Stifel Nicolaus Initiates Volcano at Hold
Wednesday, July 13, 2011 - 8:47am | 96Stifel Nicolaus is out with its report today on Volcano (NASDAQ: VOLC), initiating VOLC at Hold. In a note to clients, Stifel Nicolaus writes, "We are initiating coverage of Volcano with a Hold rating. Volcano offers imaging, visualization, and treatment tools that significantly enhance the...
-
Stifel Nicolaus Initiates SMF, VOLC
Wednesday, July 13, 2011 - 8:05am | 39Stifel Nicolaus has initiated coverage on the following companies: Salient MLP & Energy Infrastructure Fund (NYSE: SMF) Buy, $26 PT Volcano Corporation (NASDAQ: VOLC) Hold
-
News Summary for July 13, 2011
Wednesday, July 13, 2011 - 7:58am | 580This is your Benzinga news summary and traders' outlook for Wednesday, July 13, 2011, covering headlines from overnight and Wednesday’s pre-market session. Today in domestic pre-market trading, U.S. equity futures are trading higher as investors wait to see what Federal Reserve Chairman Ben...
-
Kinetic Concepts Shares Rise In Pre-Market On Acquisition News
Wednesday, July 13, 2011 - 7:29am | 78Kinetic Concepts Inc (NYSE: KCI) agreed to be bought for $6.3 billion by a consortium of private equity firm Apax Partners, as well as affiliates of Canada Pension Plan Investment Board and the Public Sector Pension Investment Board. The consortium is paying $68.50 per share in cash for the...
-
Piper Jaffray Reiterates Neutral and PT of $78 on Gen-Probe
Wednesday, July 13, 2011 - 7:24am | 46Piper Jaffray reiterated its Neutral rating on Gen-Probe (NASDAQ: GPRO). At the same time, Piper Jaffray left its price target on the company's stock unchanged at $78. On Tuesday, GPRO lost 0.67% of its value to finish the day at $65.52.
-
KCI Announces Agreement to Be Acquired by Consortium Including Apax Partners, CPPIB and PSP Investments in Transaction Valued at $6.3 Billion; Shareholders to receive $68.50 per Share
Wednesday, July 13, 2011 - 7:01am | 66Kinetic Concepts, Inc. (NYSE: KCI) today announced that it has entered into a definitive merger agreement under which a consortium comprised of funds advised by Apax Partners, together with controlled affiliates of Canada Pension Plan Investment Board and the Public Sector Pension Investment Board...
-
Morgan Stanley Provides Color on Baxter
Wednesday, July 13, 2011 - 6:30am | 162Morgan Stanley provided color on Baxter (NYSE: BAX). In a research report published today, the rating agency commented on Biogen's (NASDAQ: BIIB) new product, which does not seem to be threatening Baxter's products in the same field. In the report, Morgan Stanley states, “New pharmacokinetic data...
-
Fast Money Picks For July 13th (QCOM, SLW, COV, SWN, SPY)
Tuesday, July 12, 2011 - 7:54pm | 236On CNBC's Fast Money, Stephen Weiss said that he would buy QUALCOMM, Inc. (NASDAQ: QCOM) on Wednesday. QUALCOMM, Inc. (QCOM) fell 2.95% today, and it closed at $56.52. Guy Adami thinks that Silver Wheaton Corp. (USA) (NYSE: SLW) is a buy. Silver Wheaton Corp. (USA) (SLW) added 4.80% today, and...
-
Deutsche Bank Maintains Hold on Edwards Lifesciences
Tuesday, July 12, 2011 - 9:24am | 121Deutsche Bank is out with its report today on Edwards Lifesciences (NYSE: EW), maintaining Hold. In a note to clients, Deutsche Bank writes, "On July 20, a FDA Advisory Committee will review Edwards' PMA for SAPIEN in inoperable patients based on the PARTNER trial Cohort B results. We believe EW...